The impact of body mass index on misoprostol dosing for labor induction: a comparison of vaginal and buccal dosage forms

Further Publications Gynecology

Comparison of Two Different Dosing Regimens of Vaginal Misoprostol for Cervical Priming Among Women Undergoing Vaginoscopic Hysteroscopy: A Non-inferiority Randomized Controlled Trial

Am J Obstet Gynecol

Puttaswamy RG, Maurya DK, Subbaiah M, Gupta A, Sappani M, Thyagaraju C, Beyene J, Keepanasseril A

doi: 10.1016/j.ajog.2025.06.057

Pregnancy and Childbirth

Prophylactic oxytocin dose following vaginal birth to prevent postpartum hemorrhage: A systematic review and dose-response meta-analysis

Am J Obstet Gynecol

Hébert V, D'Souza R, Santesso N, Zeraatkar D, Oltean I, Furnivall M, Sadeghirad B, Darling EK

doi: 10.1016/j.ajog.2025.09.034

Pregnancy and Childbirth

Maximum Oxytocin Dose and Uterine Rupture During Trial of Labor After Cesarean

Obstet Gynecol

Bruno AM, Allshouse AA, Metz TD

doi: 10.1097/AOG.0000000000006106

Pregnancy and Childbirth

Sublingual or Oral Versus Vaginal Misoprostol for Cervical Priming Prior to First-Trimester Surgical Abortion: A Systematic Review and Meta-Analysis

Am J Obstet Gynecol

Queiroz LF, Lemos M, Diniz AF, Longo da Silva CM, Ferraz JM, Antunes de Oliveira Gomide PM, Luiza Dos Santos P, De Marco Novellino AM

doi: 10.1016/j.ajog.2025.11.023

Erectile and Sexual Functions and Dysfunctions

Exploring the link between muscle quality and erectile dysfunction: assessing the impact of mass and strength

Sex Med Rev

Duan M, Hernandez B, Kronstedt S, Donato J, Saffati G, Parikh N, Khera M, Lyon G

doi: 10.1093/sxmrev/qeaf033

Pregnancy and Childbirth

A comparison of progesterone via vaginal oil capsules versus pessaries for luteal phase support in assisted reproduction treatment: a multicentre cohort study of 42 291 cycles

Hum Reprod

Dhillon-Smith RK, Khairy M, Bamford T, Sephton V, Richardson A, Balen AH, Coomarasamy A

doi: 10.1093/humrep/deaf219

Further Publications Gynecology

Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial)

Hum Reprod

Bernabeu A, Zajc P, García Sánchez M, Agrawal R, Papaleo E, Jirecek S, Møgelmose S, Jepsen IE, Lobo R

doi: 10.1093/humrep/deaf119

Erectile and Sexual Functions and Dysfunctions

Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen

Eur J Cancer

Nyback S, Poromaa IS, Lindman H, Hirschberg AL, Kallner HK, Wikman A, Kallak TK

doi: 10.1016/j.ejca.2026.116261

Further Publications Gynecology

Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up

Hum Reprod

Streuli I, Ramyead L, Silvestrini N, Petignat P, Dubuisson J

doi: 10.1093/humrep/deaf070

Related content

Comparison of Two Different Dosing Regimens of Vaginal Misoprostol for Cervical Priming Among Women Undergoing Vaginoscopic Hysteroscopy: A Non-inferiority Randomized Controlled Trial

Prophylactic oxytocin dose following vaginal birth to prevent postpartum hemorrhage: A systematic review and dose-response meta-analysis

Maximum Oxytocin Dose and Uterine Rupture During Trial of Labor After Cesarean

Sublingual or Oral Versus Vaginal Misoprostol for Cervical Priming Prior to First-Trimester Surgical Abortion: A Systematic Review and Meta-Analysis

Exploring the link between muscle quality and erectile dysfunction: assessing the impact of mass and strength

A comparison of progesterone via vaginal oil capsules versus pessaries for luteal phase support in assisted reproduction treatment: a multicentre cohort study of 42 291 cycles

Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial)

Vaginal tamoxifen - A potential treatment option for vaginal atrophy symptoms in postmenopausal women who cannot use estrogen

Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up